| Domestic Sales | Manufacture and sale of pharmaceutical drugs focusing on anti-ulcerative and antibacterial segments. | Established manufacturing plant and long-term contract relationships with key pharma players. | B2B pharmaceutical companies and B2C healthcare providers and end-users in India. | Contract manufacturing services offering stable margins. | 109 | 99 | Revenue mainly from product sales and contract manufacturing services. | Sales-based revenue with negotiated contracts; some recurring orders from partners. | Increased demand for anti-ulcer and antibacterial drugs; contract manufacturing partnerships. | |
| Export Sales | Limited export of pharmaceutical products. | | International pharmaceutical and healthcare clients in limited volumes. | | 0 | 1 | Sales revenue from export orders. | Sales-based with export pricing models. | Potential expansion into export markets. | |
